TESTOSTERONE THERAPY FOR
TRANSMASCULINE TEENS
Testosterone therapy is the gender-affirming treatment that helps transmasculine teens develop masculine physical features, and it works by shifting the body toward an androgen-dominant balance that triggers the same kinds of changes as a typical male puberty. The changes appear gradually over months to years: a deeper voice, facial and body hair, more muscle, a shift in body-fat distribution, and periods stopping. It is started after assessment with a care team and, for minors, parental involvement, and it is monitored with regular follow-up. Research links this care to improved mental health and quality of life for the young people who need it.
This page uses “masculinizing hormone therapy” and “testosterone therapy” for the treatment; you may also see it called gender-affirming hormone therapy, transition-related care, or supportive care, and those terms describe the same thing. It is an overview of what to expect; the detailed side-effect discussion lives on our testosterone side effects page.
WHAT IS TESTOSTERONE THERAPY FOR
TRANSMASCULINE TEENS?
Testosterone therapy uses the hormone testosterone to promote masculine secondary sex characteristics and reduce estrogen-driven ones.
In practice, that means it does two things at once: it lowers the effects of estrogen, and it drives the development of features such as a deeper voice, facial hair, and increased muscle mass (Gender-affirming medical care of transgender youth, 2021).
It is one part of a broader plan that a young person builds with their family and care team, not a standalone step.
WHAT TO EXPECT
Changes come gradually and vary from person to person, so the timing below is a general guide rather than a schedule. Most effects begin within the first several months and continue maturing for two to five years.
Sources: voice change primarily within the first six months and effect overview, Gender-affirming medical care of transgender youth (2021); effect list and monitoring, UCSF Gender Affirming Health Program; timeline and permanence, Cleveland Clinic.
HOW IT IS GIVEN AND MONITORED
Testosterone is usually given as an injection (into muscle or under the skin) or as a topical gel. The care team checks hormone levels and health markers on a schedule, often at about three and six months early on and then periodically once things are stable (UCSF Gender Affirming Health Program). Routine blood tests also track the specific effects covered on our side effects page, such as red blood cell count and cholesterol. Fertility can be affected, which we cover on the fertility page. Testosterone is also not a contraceptive, so pregnancy remains possible.
WHO IT IS FOR, AND WHEN IT STARTS
Care is staged by pubertal development. Before puberty, no medical treatment is used; once puberty is underway, puberty-pausing medication may be an option; and masculinizing hormone therapy is generally considered later, in adolescence (Gender-affirming medical care of transgender youth, 2021). The Endocrine Society has historically pointed to around age 16 as a typical starting point, while allowing that the right timing is individual and sometimes earlier for a particular young person after careful evaluation (Cleveland Clinic). The decision involves the young person, their family, a mental-health professional, and the treating clinician, and for minors it requires parental consent.
CONTENT NOTE
This is information, not medical advice. Whether this medication is appropriate for a particular young person is a decision for that young person, their family, and their qualified healthcare providers, based on individual circumstances.
BENEFITS & WHAT THE EVIDENCE SAYS
Studies in adolescents and adults have linked gender-affirming hormone therapy, including testosterone, to lower rates of depression and anxiety and improved quality of life.
One study of transmasculine adolescents found that the effects young people reported closely matched what they had hoped for before starting (Journal of Pediatric Endocrinology and Metabolism, 2023).
As with the rest of this field, researchers note that long-term adolescent data are still limited, which is one reason care is individualized and closely monitored.
